Global Femtech

Femtech Comprehensive Study by Type (Devices, Software, Services), Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, General Healthcare & Wellness, Others), End User (Direct-to-consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers) Players and Region - Global Market Outlook to 2030

Femtech Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 16.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Femtech is a service that focuses on the personal health and hygiene of women. It comprises period-tracking apps, fertility solutions, pregnancy & nursing care, reproductive system health, contraception as well as general healthcare and wellness. Growing demand for wearable devices to accurately monitor women's health conditions are key driving factors for the growth of femtech industry outlook worldwide. The market is expected to grow in the future due to the government as well as various public and private companies are rigorously investing in women health and hygiene sector. According to AMA Research, the market for Femtech is expected to register a CAGR of 16.1% during the forecast period to 2030. This growth is primarily driven by Usage of digital technology to manage women health in developed countries .

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Technology sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Sustain Natural (United States), Hera Med Ltd (Isreal), Totohealth (Kenya), Athena Feminine Technologies, Inc. (United States), iSono Health (United States) and Sera Prognostics (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In 2021, Eastra Health emerged as the first biotech company to develop a hallucinogen-derived drug specifically for women for conditions such as PMS and menopause.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.

Influencing Trend:
Introduction of innovative femtech solutions and Increasing market demand for embryo screening, egg freezing, fertility and other services

Market Growth Drivers:
Usage of digital technology to manage women health in developed countries, Improving access to women care in remote areas and Growing demand for wearable devices to accurately monitor women health conditions

Challenges:
Lack of awareness about femtech products and applications

Restraints:
Lack of high healthcare infrastructure in some region

Opportunities:
Growing awareness regarding women health and wellness in developing countries and Increasing burden of chronic and infectious diseases among the female population

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Femtech Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Femtech Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Femtech players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Femtech Study Sheds Light on
— The Femtech Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Femtech industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Femtech industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Devices
  • Software
  • Services
By Application
  • Reproductive Health
  • Pregnancy & Nursing Care
  • Pelvic & Uterine Healthcare
  • General Healthcare & Wellness
  • Others
By End User
  • Direct-to-consumer
  • Hospitals
  • Fertility Clinics
  • Surgical Centers
  • Diagnostic Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Usage of digital technology to manage women health in developed countries
      • 3.2.2. Improving access to women care in remote areas
      • 3.2.3. Growing demand for wearable devices to accurately monitor women health conditions
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness about femtech products and applications
    • 3.4. Market Trends
      • 3.4.1. Introduction of innovative femtech solutions
      • 3.4.2. Increasing market demand for embryo screening, egg freezing, fertility and other services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Femtech, by Type, Application, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Femtech (Value)
      • 5.2.1. Global Femtech by: Type (Value)
        • 5.2.1.1. Devices
        • 5.2.1.2. Software
        • 5.2.1.3. Services
      • 5.2.2. Global Femtech by: Application (Value)
        • 5.2.2.1. Reproductive Health
        • 5.2.2.2. Pregnancy & Nursing Care
        • 5.2.2.3. Pelvic & Uterine Healthcare
        • 5.2.2.4. General Healthcare & Wellness
        • 5.2.2.5. Others
      • 5.2.3. Global Femtech by: End User (Value)
        • 5.2.3.1. Direct-to-consumer
        • 5.2.3.2. Hospitals
        • 5.2.3.3. Fertility Clinics
        • 5.2.3.4. Surgical Centers
        • 5.2.3.5. Diagnostic Centers
      • 5.2.4. Global Femtech Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Femtech: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sustain Natural (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hera Med Ltd (Isreal)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Totohealth (Kenya)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Athena Feminine Technologies, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ISono Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sera Prognostics (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Femtech Sale, by Type, Application, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Femtech (Value)
      • 7.2.1. Global Femtech by: Type (Value)
        • 7.2.1.1. Devices
        • 7.2.1.2. Software
        • 7.2.1.3. Services
      • 7.2.2. Global Femtech by: Application (Value)
        • 7.2.2.1. Reproductive Health
        • 7.2.2.2. Pregnancy & Nursing Care
        • 7.2.2.3. Pelvic & Uterine Healthcare
        • 7.2.2.4. General Healthcare & Wellness
        • 7.2.2.5. Others
      • 7.2.3. Global Femtech by: End User (Value)
        • 7.2.3.1. Direct-to-consumer
        • 7.2.3.2. Hospitals
        • 7.2.3.3. Fertility Clinics
        • 7.2.3.4. Surgical Centers
        • 7.2.3.5. Diagnostic Centers
      • 7.2.4. Global Femtech Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Femtech: by Type(USD Million)
  • Table 2. Femtech Devices , by Region USD Million (2018-2023)
  • Table 3. Femtech Software , by Region USD Million (2018-2023)
  • Table 4. Femtech Services , by Region USD Million (2018-2023)
  • Table 5. Femtech: by Application(USD Million)
  • Table 6. Femtech Reproductive Health , by Region USD Million (2018-2023)
  • Table 7. Femtech Pregnancy & Nursing Care , by Region USD Million (2018-2023)
  • Table 8. Femtech Pelvic & Uterine Healthcare , by Region USD Million (2018-2023)
  • Table 9. Femtech General Healthcare & Wellness , by Region USD Million (2018-2023)
  • Table 10. Femtech Others , by Region USD Million (2018-2023)
  • Table 11. Femtech: by End User(USD Million)
  • Table 12. Femtech Direct-to-consumer , by Region USD Million (2018-2023)
  • Table 13. Femtech Hospitals , by Region USD Million (2018-2023)
  • Table 14. Femtech Fertility Clinics , by Region USD Million (2018-2023)
  • Table 15. Femtech Surgical Centers , by Region USD Million (2018-2023)
  • Table 16. Femtech Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 17. South America Femtech, by Country USD Million (2018-2023)
  • Table 18. South America Femtech, by Type USD Million (2018-2023)
  • Table 19. South America Femtech, by Application USD Million (2018-2023)
  • Table 20. South America Femtech, by End User USD Million (2018-2023)
  • Table 21. Brazil Femtech, by Type USD Million (2018-2023)
  • Table 22. Brazil Femtech, by Application USD Million (2018-2023)
  • Table 23. Brazil Femtech, by End User USD Million (2018-2023)
  • Table 24. Argentina Femtech, by Type USD Million (2018-2023)
  • Table 25. Argentina Femtech, by Application USD Million (2018-2023)
  • Table 26. Argentina Femtech, by End User USD Million (2018-2023)
  • Table 27. Rest of South America Femtech, by Type USD Million (2018-2023)
  • Table 28. Rest of South America Femtech, by Application USD Million (2018-2023)
  • Table 29. Rest of South America Femtech, by End User USD Million (2018-2023)
  • Table 30. Asia Pacific Femtech, by Country USD Million (2018-2023)
  • Table 31. Asia Pacific Femtech, by Type USD Million (2018-2023)
  • Table 32. Asia Pacific Femtech, by Application USD Million (2018-2023)
  • Table 33. Asia Pacific Femtech, by End User USD Million (2018-2023)
  • Table 34. China Femtech, by Type USD Million (2018-2023)
  • Table 35. China Femtech, by Application USD Million (2018-2023)
  • Table 36. China Femtech, by End User USD Million (2018-2023)
  • Table 37. Japan Femtech, by Type USD Million (2018-2023)
  • Table 38. Japan Femtech, by Application USD Million (2018-2023)
  • Table 39. Japan Femtech, by End User USD Million (2018-2023)
  • Table 40. India Femtech, by Type USD Million (2018-2023)
  • Table 41. India Femtech, by Application USD Million (2018-2023)
  • Table 42. India Femtech, by End User USD Million (2018-2023)
  • Table 43. South Korea Femtech, by Type USD Million (2018-2023)
  • Table 44. South Korea Femtech, by Application USD Million (2018-2023)
  • Table 45. South Korea Femtech, by End User USD Million (2018-2023)
  • Table 46. Taiwan Femtech, by Type USD Million (2018-2023)
  • Table 47. Taiwan Femtech, by Application USD Million (2018-2023)
  • Table 48. Taiwan Femtech, by End User USD Million (2018-2023)
  • Table 49. Australia Femtech, by Type USD Million (2018-2023)
  • Table 50. Australia Femtech, by Application USD Million (2018-2023)
  • Table 51. Australia Femtech, by End User USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Femtech, by Type USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Femtech, by Application USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Femtech, by End User USD Million (2018-2023)
  • Table 55. Europe Femtech, by Country USD Million (2018-2023)
  • Table 56. Europe Femtech, by Type USD Million (2018-2023)
  • Table 57. Europe Femtech, by Application USD Million (2018-2023)
  • Table 58. Europe Femtech, by End User USD Million (2018-2023)
  • Table 59. Germany Femtech, by Type USD Million (2018-2023)
  • Table 60. Germany Femtech, by Application USD Million (2018-2023)
  • Table 61. Germany Femtech, by End User USD Million (2018-2023)
  • Table 62. France Femtech, by Type USD Million (2018-2023)
  • Table 63. France Femtech, by Application USD Million (2018-2023)
  • Table 64. France Femtech, by End User USD Million (2018-2023)
  • Table 65. Italy Femtech, by Type USD Million (2018-2023)
  • Table 66. Italy Femtech, by Application USD Million (2018-2023)
  • Table 67. Italy Femtech, by End User USD Million (2018-2023)
  • Table 68. United Kingdom Femtech, by Type USD Million (2018-2023)
  • Table 69. United Kingdom Femtech, by Application USD Million (2018-2023)
  • Table 70. United Kingdom Femtech, by End User USD Million (2018-2023)
  • Table 71. Netherlands Femtech, by Type USD Million (2018-2023)
  • Table 72. Netherlands Femtech, by Application USD Million (2018-2023)
  • Table 73. Netherlands Femtech, by End User USD Million (2018-2023)
  • Table 74. Rest of Europe Femtech, by Type USD Million (2018-2023)
  • Table 75. Rest of Europe Femtech, by Application USD Million (2018-2023)
  • Table 76. Rest of Europe Femtech, by End User USD Million (2018-2023)
  • Table 77. MEA Femtech, by Country USD Million (2018-2023)
  • Table 78. MEA Femtech, by Type USD Million (2018-2023)
  • Table 79. MEA Femtech, by Application USD Million (2018-2023)
  • Table 80. MEA Femtech, by End User USD Million (2018-2023)
  • Table 81. Middle East Femtech, by Type USD Million (2018-2023)
  • Table 82. Middle East Femtech, by Application USD Million (2018-2023)
  • Table 83. Middle East Femtech, by End User USD Million (2018-2023)
  • Table 84. Africa Femtech, by Type USD Million (2018-2023)
  • Table 85. Africa Femtech, by Application USD Million (2018-2023)
  • Table 86. Africa Femtech, by End User USD Million (2018-2023)
  • Table 87. North America Femtech, by Country USD Million (2018-2023)
  • Table 88. North America Femtech, by Type USD Million (2018-2023)
  • Table 89. North America Femtech, by Application USD Million (2018-2023)
  • Table 90. North America Femtech, by End User USD Million (2018-2023)
  • Table 91. United States Femtech, by Type USD Million (2018-2023)
  • Table 92. United States Femtech, by Application USD Million (2018-2023)
  • Table 93. United States Femtech, by End User USD Million (2018-2023)
  • Table 94. Canada Femtech, by Type USD Million (2018-2023)
  • Table 95. Canada Femtech, by Application USD Million (2018-2023)
  • Table 96. Canada Femtech, by End User USD Million (2018-2023)
  • Table 97. Mexico Femtech, by Type USD Million (2018-2023)
  • Table 98. Mexico Femtech, by Application USD Million (2018-2023)
  • Table 99. Mexico Femtech, by End User USD Million (2018-2023)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Femtech: by Type(USD Million)
  • Table 107. Femtech Devices , by Region USD Million (2025-2030)
  • Table 108. Femtech Software , by Region USD Million (2025-2030)
  • Table 109. Femtech Services , by Region USD Million (2025-2030)
  • Table 110. Femtech: by Application(USD Million)
  • Table 111. Femtech Reproductive Health , by Region USD Million (2025-2030)
  • Table 112. Femtech Pregnancy & Nursing Care , by Region USD Million (2025-2030)
  • Table 113. Femtech Pelvic & Uterine Healthcare , by Region USD Million (2025-2030)
  • Table 114. Femtech General Healthcare & Wellness , by Region USD Million (2025-2030)
  • Table 115. Femtech Others , by Region USD Million (2025-2030)
  • Table 116. Femtech: by End User(USD Million)
  • Table 117. Femtech Direct-to-consumer , by Region USD Million (2025-2030)
  • Table 118. Femtech Hospitals , by Region USD Million (2025-2030)
  • Table 119. Femtech Fertility Clinics , by Region USD Million (2025-2030)
  • Table 120. Femtech Surgical Centers , by Region USD Million (2025-2030)
  • Table 121. Femtech Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 122. South America Femtech, by Country USD Million (2025-2030)
  • Table 123. South America Femtech, by Type USD Million (2025-2030)
  • Table 124. South America Femtech, by Application USD Million (2025-2030)
  • Table 125. South America Femtech, by End User USD Million (2025-2030)
  • Table 126. Brazil Femtech, by Type USD Million (2025-2030)
  • Table 127. Brazil Femtech, by Application USD Million (2025-2030)
  • Table 128. Brazil Femtech, by End User USD Million (2025-2030)
  • Table 129. Argentina Femtech, by Type USD Million (2025-2030)
  • Table 130. Argentina Femtech, by Application USD Million (2025-2030)
  • Table 131. Argentina Femtech, by End User USD Million (2025-2030)
  • Table 132. Rest of South America Femtech, by Type USD Million (2025-2030)
  • Table 133. Rest of South America Femtech, by Application USD Million (2025-2030)
  • Table 134. Rest of South America Femtech, by End User USD Million (2025-2030)
  • Table 135. Asia Pacific Femtech, by Country USD Million (2025-2030)
  • Table 136. Asia Pacific Femtech, by Type USD Million (2025-2030)
  • Table 137. Asia Pacific Femtech, by Application USD Million (2025-2030)
  • Table 138. Asia Pacific Femtech, by End User USD Million (2025-2030)
  • Table 139. China Femtech, by Type USD Million (2025-2030)
  • Table 140. China Femtech, by Application USD Million (2025-2030)
  • Table 141. China Femtech, by End User USD Million (2025-2030)
  • Table 142. Japan Femtech, by Type USD Million (2025-2030)
  • Table 143. Japan Femtech, by Application USD Million (2025-2030)
  • Table 144. Japan Femtech, by End User USD Million (2025-2030)
  • Table 145. India Femtech, by Type USD Million (2025-2030)
  • Table 146. India Femtech, by Application USD Million (2025-2030)
  • Table 147. India Femtech, by End User USD Million (2025-2030)
  • Table 148. South Korea Femtech, by Type USD Million (2025-2030)
  • Table 149. South Korea Femtech, by Application USD Million (2025-2030)
  • Table 150. South Korea Femtech, by End User USD Million (2025-2030)
  • Table 151. Taiwan Femtech, by Type USD Million (2025-2030)
  • Table 152. Taiwan Femtech, by Application USD Million (2025-2030)
  • Table 153. Taiwan Femtech, by End User USD Million (2025-2030)
  • Table 154. Australia Femtech, by Type USD Million (2025-2030)
  • Table 155. Australia Femtech, by Application USD Million (2025-2030)
  • Table 156. Australia Femtech, by End User USD Million (2025-2030)
  • Table 157. Rest of Asia-Pacific Femtech, by Type USD Million (2025-2030)
  • Table 158. Rest of Asia-Pacific Femtech, by Application USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Femtech, by End User USD Million (2025-2030)
  • Table 160. Europe Femtech, by Country USD Million (2025-2030)
  • Table 161. Europe Femtech, by Type USD Million (2025-2030)
  • Table 162. Europe Femtech, by Application USD Million (2025-2030)
  • Table 163. Europe Femtech, by End User USD Million (2025-2030)
  • Table 164. Germany Femtech, by Type USD Million (2025-2030)
  • Table 165. Germany Femtech, by Application USD Million (2025-2030)
  • Table 166. Germany Femtech, by End User USD Million (2025-2030)
  • Table 167. France Femtech, by Type USD Million (2025-2030)
  • Table 168. France Femtech, by Application USD Million (2025-2030)
  • Table 169. France Femtech, by End User USD Million (2025-2030)
  • Table 170. Italy Femtech, by Type USD Million (2025-2030)
  • Table 171. Italy Femtech, by Application USD Million (2025-2030)
  • Table 172. Italy Femtech, by End User USD Million (2025-2030)
  • Table 173. United Kingdom Femtech, by Type USD Million (2025-2030)
  • Table 174. United Kingdom Femtech, by Application USD Million (2025-2030)
  • Table 175. United Kingdom Femtech, by End User USD Million (2025-2030)
  • Table 176. Netherlands Femtech, by Type USD Million (2025-2030)
  • Table 177. Netherlands Femtech, by Application USD Million (2025-2030)
  • Table 178. Netherlands Femtech, by End User USD Million (2025-2030)
  • Table 179. Rest of Europe Femtech, by Type USD Million (2025-2030)
  • Table 180. Rest of Europe Femtech, by Application USD Million (2025-2030)
  • Table 181. Rest of Europe Femtech, by End User USD Million (2025-2030)
  • Table 182. MEA Femtech, by Country USD Million (2025-2030)
  • Table 183. MEA Femtech, by Type USD Million (2025-2030)
  • Table 184. MEA Femtech, by Application USD Million (2025-2030)
  • Table 185. MEA Femtech, by End User USD Million (2025-2030)
  • Table 186. Middle East Femtech, by Type USD Million (2025-2030)
  • Table 187. Middle East Femtech, by Application USD Million (2025-2030)
  • Table 188. Middle East Femtech, by End User USD Million (2025-2030)
  • Table 189. Africa Femtech, by Type USD Million (2025-2030)
  • Table 190. Africa Femtech, by Application USD Million (2025-2030)
  • Table 191. Africa Femtech, by End User USD Million (2025-2030)
  • Table 192. North America Femtech, by Country USD Million (2025-2030)
  • Table 193. North America Femtech, by Type USD Million (2025-2030)
  • Table 194. North America Femtech, by Application USD Million (2025-2030)
  • Table 195. North America Femtech, by End User USD Million (2025-2030)
  • Table 196. United States Femtech, by Type USD Million (2025-2030)
  • Table 197. United States Femtech, by Application USD Million (2025-2030)
  • Table 198. United States Femtech, by End User USD Million (2025-2030)
  • Table 199. Canada Femtech, by Type USD Million (2025-2030)
  • Table 200. Canada Femtech, by Application USD Million (2025-2030)
  • Table 201. Canada Femtech, by End User USD Million (2025-2030)
  • Table 202. Mexico Femtech, by Type USD Million (2025-2030)
  • Table 203. Mexico Femtech, by Application USD Million (2025-2030)
  • Table 204. Mexico Femtech, by End User USD Million (2025-2030)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Femtech: by Type USD Million (2018-2023)
  • Figure 5. Global Femtech: by Application USD Million (2018-2023)
  • Figure 6. Global Femtech: by End User USD Million (2018-2023)
  • Figure 7. South America Femtech Share (%), by Country
  • Figure 8. Asia Pacific Femtech Share (%), by Country
  • Figure 9. Europe Femtech Share (%), by Country
  • Figure 10. MEA Femtech Share (%), by Country
  • Figure 11. North America Femtech Share (%), by Country
  • Figure 12. Global Femtech share by Players 2023 (%)
  • Figure 13. Global Femtech share by Players (Top 3) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Sustain Natural (United States) Revenue, Net Income and Gross profit
  • Figure 16. Sustain Natural (United States) Revenue: by Geography 2023
  • Figure 17. Hera Med Ltd (Isreal) Revenue, Net Income and Gross profit
  • Figure 18. Hera Med Ltd (Isreal) Revenue: by Geography 2023
  • Figure 19. Totohealth (Kenya) Revenue, Net Income and Gross profit
  • Figure 20. Totohealth (Kenya) Revenue: by Geography 2023
  • Figure 21. Athena Feminine Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Athena Feminine Technologies, Inc. (United States) Revenue: by Geography 2023
  • Figure 23. ISono Health (United States) Revenue, Net Income and Gross profit
  • Figure 24. ISono Health (United States) Revenue: by Geography 2023
  • Figure 25. Sera Prognostics (United States) Revenue, Net Income and Gross profit
  • Figure 26. Sera Prognostics (United States) Revenue: by Geography 2023
  • Figure 27. Global Femtech: by Type USD Million (2025-2030)
  • Figure 28. Global Femtech: by Application USD Million (2025-2030)
  • Figure 29. Global Femtech: by End User USD Million (2025-2030)
  • Figure 30. South America Femtech Share (%), by Country
  • Figure 31. Asia Pacific Femtech Share (%), by Country
  • Figure 32. Europe Femtech Share (%), by Country
  • Figure 33. MEA Femtech Share (%), by Country
  • Figure 34. North America Femtech Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sustain Natural (United States)
  • Hera Med Ltd (Isreal)
  • Totohealth (Kenya)
  • Athena Feminine Technologies, Inc. (United States)
  • iSono Health (United States)
  • Sera Prognostics (United States)
Additional players considered in the study are as follows:
Elvie (United Kingdom) , Univfy (United States) , Conceivable (United States)
Select User Access Type

Key Highlights of Report


Aug 2024 168 Pages 85 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Femtech Quantitative research analysis
Global Femtech Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Femtech Market are Sustain Natural (United States), Hera Med Ltd (Isreal), Totohealth (Kenya), Athena Feminine Technologies, Inc. (United States), iSono Health (United States) and Sera Prognostics (United States) etc.
Reproductive Health segment in Global market to hold robust market share owing to "Usage of digital technology to manage women health in developed countries ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Femtech market throughout the forecasted period.

Know More About Global Femtech Report?

Have a Query? Click Here

Other Related Reports

Population Health Management Systems Comprehensive Study by Type (Software, Services), Application (Automating Patient-Centered Medical Home (PCMH), Access Comprehensive Longitudinal Patient Record, ...
$ 3650
Computer Vision in Healthcare Comprehensive Study by Type (Hardware (Processors (CPUs, GPUs, FPGAs, ASICs, VPUs), Memory Devices, Networks), Software (Cloud-based, On-premise), Services), Application...
$ 3750
Dynamic Spinal Tethering System Comprehensive Study by Application (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), Disease Type (Scoliosis, Other Spine Deformities), End-users (Adults, C...
$ 3500
Surgical Instruments Tracking Systems Comprehensive Study by Technology (Barcodes, RFID), Offering (Hardware, Software), End-User (Hospitals, Clinics, Others) Players and Region - Global Market Outl...
$ 3500
Health Kiosk Comprehensive Study by Type (Check-in Kiosks, Payment Kiosks, Way Finding Kiosks, Telemedicine Kiosks, Self-service/ Informative Kiosks, Electronic Medical Record Management Kiosks), End...
$ 3450
Photomedicine Technology Comprehensive Study by Type (Laser, Polychromatic Polarized Light, Full Spectrum Light, Dichroic Lamps, Light Emitting Diodes), Application (Surgery, Dermatology, Cardiology,...
$ 3350